Research workbench
AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (B4L629)
Analyse AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (B4L629) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- Accession
- B4L629
- Type
- protein
- Length
- 380 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x903d68EF8d4158E11a1CE5C12dC20a18D2164C5b
- Molecule
- Tryptophan 2,3-dioxygenase
- UniProt
- B4L629
- Pockets
- 2 · best druggability 0.80
Structure
1 distinct chain · 66% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tryptophan 2,3-dioxygenase | protein | 380 | 66% helix, 0% strand | B4L629 |
Pockets
2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 486 | 0.80 | 0.87 | 47 | empty |
| 2 | 196 | 0.59 | 0.81 | 22 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt B4L629
- Elsewhere: UniProt B4L629 · AlphaFold DB B4L629
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.